GPCR / G Protein
-
Atrasentan
Catalog No. A13779 ETA 拮抗剂Atrasentan是一种实验药物,正在研究中,用于治疗各种类型的癌症,包括非小细胞肺癌。它是对A型亚型(ETA)有选择性的内皮素受体拮抗剂,对ETA的IC50为0.0551 nM。 了解更多 -
Atrasentan HCl
Catalog No. A15007 Endothelin 拮抗剂 receptorAtrasentan hydrochloride是一种开发用于治疗前列腺癌的内皮素拮抗剂受体(IC50 = 0.0551 nM,ETA)。 了解更多 -
BQ-123
Catalog No. A15912 -
Bosentan Hydrate
Catalog No. A14944 -
Macitentan
Catalog No. A11492 Endothelin receptor 拮抗剂Macitentan是一种口服活性非肽双重ETA/ETB(内皮素) receptor双重拮抗剂,IC50为0.5 nM/391 nM。用于治疗特发性肺纤维化(IPF)和肺动脉高压(PAH)。 了解更多 -
Sparsentan
Catalog No. A20879 angiotensin II and endothelin A receptor antagonistSparsentan (RE-021) is a highly potent dual angiotensin II and endothelin A receptor antagonist with Kis of 0.8 and 9.3 nM, respectively. 了解更多 -
Tezosentan
Catalog No. A21118 endothelin (ET) receptor antagonistTezosentan (RO 610612) is an endothelin (ET) receptor antagonist, with pA2s of 9.5, 7.7 for ETA and ETB receptors, respectively. 了解更多 -
Darusentan
Catalog No. A21280 endothelin A (ETA) receptor antagonistDarusentan is a selective endothelin A (ETA) receptor antagonist. 了解更多 -
Macitentan (n-butyl analogue)
Catalog No. A21845 endothelin ETA and ETB receptor antagonistMacitentan n-butyl analogue is a n-butyl analogue of Macitentan. Macitentan is an orally active, non-peptide dual endothelin ETA and ETB receptor antagonist for the potential treatment of idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH). 了解更多 -
Aprocitentan
Catalog No. A21999 dual ETA/ETB antagonistAprocitentan (ACT-132577) is the major and pharmacologically active metabolite of Macitentan. Aprocitentan is dual ETA/ETB antagonist with IC50s of 3.4 nM and 987 nM, and pA2 valus of 6.7 and 5.5, respectively. 了解更多 -
Ginkgolide B
Catalog No. A10429 -
48740 RP
Catalog No. A12339 -
Aglafoline
Catalog No. A12257 PAF antagonistAglafoline is an effective PAF antagonist not only in vitro, but also in vivo. 了解更多 -
Foropafant
Catalog No. A13388 PAF receptor antagonistForopafant (SR27417) highly potent, competitive, selective and orally active antagonist of platelet-activating factor (PAF) receptor. 了解更多 -
CID16020046
Catalog No. A16818 GPR55 拮抗剂CID16020046是一种选择性的GPR55拮抗剂,在酵母中抑制GPR55的组成活性,IC50为150 nM。它对其他广谱GPCRs、离子通道、激酶和核受体表现出弱活性。 了解更多 -
GW-1100
Catalog No. A11445 -
GPR4 antagonist 1
Catalog No. A12340 -
Plerixafor 8HCl (DB06809)
Catalog No. A10913 CXCR4 拮抗剂Plerixafor 8HCl (DB06809)是CXCR4趋化因子受体拮抗剂,作用于CXCR4和CXCL12介导调节的趋化性, IC50分别为44 nM和5.7 nM。 了解更多 -
AMD 070
Catalog No. A11315 -
AMD 3465 Hexahydrobromide
Catalog No. A11953 CXCR4 拮抗剂AMD 3465 Hexahydrobromide是一种有效的选择性CXCR4拮抗剂。 了解更多 -
AMD3100 (Plerixafor)
Catalog No. A13074 CXCR4 拮抗剂AMD3100 (Plerixafor)是用于增殖造血干细胞的免疫刺激剂,并且是用于动员造血干细胞进行移植的趋化因子受体-4拮抗剂。 了解更多 -
SCH-527123 (Navarixin)
Catalog No. A11555 CXCR1/CXCR2 拮抗剂SCH-527123 (Navarixin)是人CXCR1和CXCR2受体的强效选择性拮抗剂,IC50分别为42 nM和3 nM。 了解更多 -
AMD-070 HCl
Catalog No. A14997 CXCR4 拮抗剂在CXCR4 125I-SDF抑制结合试验中,AMD-070 HCl是一种有效的选择性CXCR4拮抗剂,IC50值为13 nM,抑制T-4型HIV-1(NL4.3株)在MT-4细胞中的复制和PBMC。 了解更多 -
CXCR2-IN-1
Catalog No. A12649 CXCR2 激动剂CXCR2-IN-1 is a central nervous system penetrant CXCR2 antagonists with a pIC50 of 9.3. 了解更多 -
SCH 563705
Catalog No. A15234 -
AZD-5069
Catalog No. A15941 -
SCH 546738
Catalog No. A21554 CXCR3 antagonistSCH 546738 is a potent, orally active and non-competitive CXCR3 antagonist, the affinity constant (Ki) of SCH 546738 binding to human CXCR3 receptor is determined to be 0.4 nM in multiple experiments. 了解更多 -
AMG 487 S-enantiomer
Catalog No. A21874 CXCR3 antagonistAMG 487 S-enantiomer is the S enantiomer of AMG 487. AMG 487 is an antagonist of the chemokine receptor CXCR3. 了解更多 -
LDE225 (NVP-LDE225, Sonidegib)
Catalog No. A10520 Smo 拮抗剂LDE225 (NVP-LDE225)是一种强效、选择性和口服生物可利用的平滑(SMO)拮抗剂,通过平滑受体(SMO)的拮抗作用抑制hedgehog (Hh)信号通路。 了解更多 -
LY2940680 (Taladegib)
Catalog No. A11048